Page last updated: 2024-10-27

gabexate and Arrhythmia

gabexate has been researched along with Arrhythmia in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research Excerpts

ExcerptRelevanceReference
"Endotoxic shock was induced in rabbits of either sex by IV injection of 50 micrograms/kg endotoxin (ET) extracted from E coli O-55 by Boivin's method."1.27Effects of gabexate mesilate on the reactions of lipid metabolism in endotoxic shock. ( Drysch, K; Poetter, E; Richardt, G; Rox, G; Schmahl, FW; Wabnitz, RW, 1983)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmahl, FW1
Wabnitz, RW1
Rox, G1
Drysch, K1
Richardt, G1
Poetter, E1

Other Studies

1 other study available for gabexate and Arrhythmia

ArticleYear
Effects of gabexate mesilate on the reactions of lipid metabolism in endotoxic shock.
    Advances in shock research, 1983, Volume: 9

    Topics: Animals; Arrhythmias, Cardiac; Endotoxins; Fatty Acids, Nonesterified; Female; Gabexate; Glycerol; G

1983